Abstract: An composition comprising: a homopolycarbonate; a poly(carbonate-siloxane) having a siloxane content of 30-70 wt %, preferably 35-65 wt %, based on the total weight of the poly(carbonate-siloxane) present in an amount effective to provide 2-10 wt % total siloxane, based on the total weight of the composition; an antimicrobial agent, wherein the antimicrobial agent is a silver zinc zeolite powder, wherein the antimicrobial agent is present in amount effective to provide up to 1000 parts per million of elemental silver based on the total weight of the composition and optionally, an additive composition.

Abstract: A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and dosage forms thereof.

Abstract: A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and dosage forms thereof.

Abstract: A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and dosage forms thereof.

Abstract: Detecting analytes using proximity-induced tagmentation, strand invasion, restriction, or ligation is provided herein. In some examples, detecting an analyte includes coupling a donor recognition probe to a first portion of the analyte. The donor recognition probe includes a first recognition element specific to the first portion of the analyte, a first oligonucleotide corresponding to the first portion, and a transposase coupled to the first recognition element and the first oligonucleotide. An acceptor recognition probe is coupled to a second portion of the analyte. The acceptor recognition probe includes a second recognition element specific to the second portion of the analyte and a second oligonucleotide coupled to the second recognition element and corresponding to the second portion. The transposase is used to generate a reporter polynucleotide including the first and second oligonucleotides. The analyte is detected based on the reporter including comprising the first and second oligonucleotides.

Abstract: Among other things, the present disclosure provides various agents. In some embodiments, provided agents can bind to beta-catenin. In some embodiments, the present disclosure provides technologies for modulating beta-catenin functions. In some embodiments, the present disclosure provides technologies for preventing and/or treating conditions, disorders or diseases associated with beta-catenin. In some embodiments, the present disclosure provides designed amino acids which can provide improved properties and/or activities. In some embodiments, the present disclosure provides agents comprising such amino acids.

Abstract: Methods for treating B-cell malignancies such as relapsed and/or refractory B-cell malignancies with a population of genetically engineered T cells expressing a chimeric antigen receptor (CAR) targeting CD19 and having multiple genetic edits, including a disrupted TRAC gene, a disrupted ?2M gene, a disrupted Regnase 1 gene, and/or a disrupted TGFBRII gene.

Abstract: In one aspect, the disclosure relates to free-standing artificial muscles having a polymeric core encased by an elastic spring. The polymeric core can be any two-way shape memory polymer including, but not limited to, a semicrystalline polymer (polybutadiene polymer, a polycaprolactone polymer, a poly(ethylene-co-vinyl acetate)), a rubber, an ionomer, an elastomer, or a gel. In some aspects, the shape memory polymers are crosslinked. In an alternative aspect, the polymeric core is a twisted and coiled polymeric fiber. In other aspects, the polymeric core is reprocessable, remoldable, and/or recyclable. In one aspect, the elastic spring is metallic, ceramic, plastic, or any combination thereof. The stiffnesses or spring rate of the elastic spring and polymeric core, the two-way shape memory effect of the polymeric core, and their geometrical dimensions can be optimized to maximize the actuation strain based on theoretical principles described herein.

Abstract: A compound having the general structure of Formula (I): or a pharmaceutically acceptable salt, solvate, or ester thereof, are useful in treating diseases, disorders, or conditions such as metabolic syndrome (e.g., obesity, waist circumference, lipid profile, and insulin sensitivity), neuroinflammatory disorders, cognitive disorders, psychosis, addictive behavior, gastrointestinal disorders, and cardiovascular conditions.